The clinical significance of metastatic breast carcinoma to intramammary lymph node

Thaer Khoury, Yisheng Fang, Rouzan Karabakhtsian, Mohamed Mokhtar Desouki, Anupma Nayak, Mathew Hanna, Souzan Sanati, Xuan Peng, Li Yan, Xiaoxian Li, Oluwole Fadare, Christine Ambrosone, Nashwan Jabbour, Carmelo Gaudioso

Research output: Contribution to journalArticle

Abstract

The incidence of involved intramammary lymph node (intra-MLN) with breast carcinoma (BC) is rare. Its clinical significance and impact on the clinical decision making is unclear. A total of 113 BC cases with at least one positive intra-MLN were collected from 11 academic institutions. The inclusion criteria were subsequent axillary lymph node dissection, and the availability of information on T-stage, size of node metastasis, extranodal extension status, biomarkers status, and clinical follow-up. Stage 4 cases and/or neo-adjuvant treated patients were excluded. AJCC TN-stage was calculated twice, with and without intra-MLN. Five-year overall survival (OS) and relapse (local and/or distant)-free survival (RFS) were calculated and correlated with the clinicopathologic variables. Excluding intra-MLN, TN-stage correlated with OS (P =.016) but not with RFS (P =.19). However, when intra-MLN was included, TN-stage correlated with both OS (P <.001) and RFS (P =.016). In the multivariate analysis, when intra-MLN was excluded, only radiation therapy (RT) correlated with RFS (HR = 0.19, 95% CI: 0.054-0.66, P =.009). However, when intra-MLN was included in the TN-stage both RT (HR = 0.13, 95% CI: 0.04-0.45, P =.001) and TN-stage 3 (HR = 8.92, 95% CI: 1.47-54, P =.017) correlated with RFS. Tumor multifocality was the only variable correlated with OS when the intra-MLN involvement was excluded. When intra-MLN was included, multifocality became insignificant but TN-stage 3 correlated with OS (HR = 8.59, 95% CI: 1.06-69.71, P =.044). Positive intra-MLN is an independent factor in predicting both RFS and OS.

Original languageEnglish (US)
JournalBreast Journal
DOIs
StateAccepted/In press - Jan 1 2019
Externally publishedYes

Fingerprint

Lymph Nodes
Breast Neoplasms
Survival
Radiotherapy
Lymph Node Excision
Multivariate Analysis
Biomarkers
Neoplasm Metastasis
Recurrence
Incidence
Neoplasms

Keywords

  • intramammary
  • lymph node
  • prognosis
  • sentinel

ASJC Scopus subject areas

  • Internal Medicine
  • Surgery
  • Oncology

Cite this

Khoury, T., Fang, Y., Karabakhtsian, R., Mokhtar Desouki, M., Nayak, A., Hanna, M., ... Gaudioso, C. (Accepted/In press). The clinical significance of metastatic breast carcinoma to intramammary lymph node. Breast Journal. https://doi.org/10.1111/tbj.13636

The clinical significance of metastatic breast carcinoma to intramammary lymph node. / Khoury, Thaer; Fang, Yisheng; Karabakhtsian, Rouzan; Mokhtar Desouki, Mohamed; Nayak, Anupma; Hanna, Mathew; Sanati, Souzan; Peng, Xuan; Yan, Li; Li, Xiaoxian; Fadare, Oluwole; Ambrosone, Christine; Jabbour, Nashwan; Gaudioso, Carmelo.

In: Breast Journal, 01.01.2019.

Research output: Contribution to journalArticle

Khoury, T, Fang, Y, Karabakhtsian, R, Mokhtar Desouki, M, Nayak, A, Hanna, M, Sanati, S, Peng, X, Yan, L, Li, X, Fadare, O, Ambrosone, C, Jabbour, N & Gaudioso, C 2019, 'The clinical significance of metastatic breast carcinoma to intramammary lymph node', Breast Journal. https://doi.org/10.1111/tbj.13636
Khoury, Thaer ; Fang, Yisheng ; Karabakhtsian, Rouzan ; Mokhtar Desouki, Mohamed ; Nayak, Anupma ; Hanna, Mathew ; Sanati, Souzan ; Peng, Xuan ; Yan, Li ; Li, Xiaoxian ; Fadare, Oluwole ; Ambrosone, Christine ; Jabbour, Nashwan ; Gaudioso, Carmelo. / The clinical significance of metastatic breast carcinoma to intramammary lymph node. In: Breast Journal. 2019.
@article{5f102de634cc494694ea75015525235d,
title = "The clinical significance of metastatic breast carcinoma to intramammary lymph node",
abstract = "The incidence of involved intramammary lymph node (intra-MLN) with breast carcinoma (BC) is rare. Its clinical significance and impact on the clinical decision making is unclear. A total of 113 BC cases with at least one positive intra-MLN were collected from 11 academic institutions. The inclusion criteria were subsequent axillary lymph node dissection, and the availability of information on T-stage, size of node metastasis, extranodal extension status, biomarkers status, and clinical follow-up. Stage 4 cases and/or neo-adjuvant treated patients were excluded. AJCC TN-stage was calculated twice, with and without intra-MLN. Five-year overall survival (OS) and relapse (local and/or distant)-free survival (RFS) were calculated and correlated with the clinicopathologic variables. Excluding intra-MLN, TN-stage correlated with OS (P =.016) but not with RFS (P =.19). However, when intra-MLN was included, TN-stage correlated with both OS (P <.001) and RFS (P =.016). In the multivariate analysis, when intra-MLN was excluded, only radiation therapy (RT) correlated with RFS (HR = 0.19, 95{\%} CI: 0.054-0.66, P =.009). However, when intra-MLN was included in the TN-stage both RT (HR = 0.13, 95{\%} CI: 0.04-0.45, P =.001) and TN-stage 3 (HR = 8.92, 95{\%} CI: 1.47-54, P =.017) correlated with RFS. Tumor multifocality was the only variable correlated with OS when the intra-MLN involvement was excluded. When intra-MLN was included, multifocality became insignificant but TN-stage 3 correlated with OS (HR = 8.59, 95{\%} CI: 1.06-69.71, P =.044). Positive intra-MLN is an independent factor in predicting both RFS and OS.",
keywords = "intramammary, lymph node, prognosis, sentinel",
author = "Thaer Khoury and Yisheng Fang and Rouzan Karabakhtsian and {Mokhtar Desouki}, Mohamed and Anupma Nayak and Mathew Hanna and Souzan Sanati and Xuan Peng and Li Yan and Xiaoxian Li and Oluwole Fadare and Christine Ambrosone and Nashwan Jabbour and Carmelo Gaudioso",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/tbj.13636",
language = "English (US)",
journal = "Breast Journal",
issn = "1075-122X",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - The clinical significance of metastatic breast carcinoma to intramammary lymph node

AU - Khoury, Thaer

AU - Fang, Yisheng

AU - Karabakhtsian, Rouzan

AU - Mokhtar Desouki, Mohamed

AU - Nayak, Anupma

AU - Hanna, Mathew

AU - Sanati, Souzan

AU - Peng, Xuan

AU - Yan, Li

AU - Li, Xiaoxian

AU - Fadare, Oluwole

AU - Ambrosone, Christine

AU - Jabbour, Nashwan

AU - Gaudioso, Carmelo

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The incidence of involved intramammary lymph node (intra-MLN) with breast carcinoma (BC) is rare. Its clinical significance and impact on the clinical decision making is unclear. A total of 113 BC cases with at least one positive intra-MLN were collected from 11 academic institutions. The inclusion criteria were subsequent axillary lymph node dissection, and the availability of information on T-stage, size of node metastasis, extranodal extension status, biomarkers status, and clinical follow-up. Stage 4 cases and/or neo-adjuvant treated patients were excluded. AJCC TN-stage was calculated twice, with and without intra-MLN. Five-year overall survival (OS) and relapse (local and/or distant)-free survival (RFS) were calculated and correlated with the clinicopathologic variables. Excluding intra-MLN, TN-stage correlated with OS (P =.016) but not with RFS (P =.19). However, when intra-MLN was included, TN-stage correlated with both OS (P <.001) and RFS (P =.016). In the multivariate analysis, when intra-MLN was excluded, only radiation therapy (RT) correlated with RFS (HR = 0.19, 95% CI: 0.054-0.66, P =.009). However, when intra-MLN was included in the TN-stage both RT (HR = 0.13, 95% CI: 0.04-0.45, P =.001) and TN-stage 3 (HR = 8.92, 95% CI: 1.47-54, P =.017) correlated with RFS. Tumor multifocality was the only variable correlated with OS when the intra-MLN involvement was excluded. When intra-MLN was included, multifocality became insignificant but TN-stage 3 correlated with OS (HR = 8.59, 95% CI: 1.06-69.71, P =.044). Positive intra-MLN is an independent factor in predicting both RFS and OS.

AB - The incidence of involved intramammary lymph node (intra-MLN) with breast carcinoma (BC) is rare. Its clinical significance and impact on the clinical decision making is unclear. A total of 113 BC cases with at least one positive intra-MLN were collected from 11 academic institutions. The inclusion criteria were subsequent axillary lymph node dissection, and the availability of information on T-stage, size of node metastasis, extranodal extension status, biomarkers status, and clinical follow-up. Stage 4 cases and/or neo-adjuvant treated patients were excluded. AJCC TN-stage was calculated twice, with and without intra-MLN. Five-year overall survival (OS) and relapse (local and/or distant)-free survival (RFS) were calculated and correlated with the clinicopathologic variables. Excluding intra-MLN, TN-stage correlated with OS (P =.016) but not with RFS (P =.19). However, when intra-MLN was included, TN-stage correlated with both OS (P <.001) and RFS (P =.016). In the multivariate analysis, when intra-MLN was excluded, only radiation therapy (RT) correlated with RFS (HR = 0.19, 95% CI: 0.054-0.66, P =.009). However, when intra-MLN was included in the TN-stage both RT (HR = 0.13, 95% CI: 0.04-0.45, P =.001) and TN-stage 3 (HR = 8.92, 95% CI: 1.47-54, P =.017) correlated with RFS. Tumor multifocality was the only variable correlated with OS when the intra-MLN involvement was excluded. When intra-MLN was included, multifocality became insignificant but TN-stage 3 correlated with OS (HR = 8.59, 95% CI: 1.06-69.71, P =.044). Positive intra-MLN is an independent factor in predicting both RFS and OS.

KW - intramammary

KW - lymph node

KW - prognosis

KW - sentinel

UR - http://www.scopus.com/inward/record.url?scp=85073922038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073922038&partnerID=8YFLogxK

U2 - 10.1111/tbj.13636

DO - 10.1111/tbj.13636

M3 - Article

C2 - 31588665

AN - SCOPUS:85073922038

JO - Breast Journal

JF - Breast Journal

SN - 1075-122X

ER -